serum
-
not specified
RT-qPCR; Clinical Sample Validation; ROC Analysis
Serum circFBXW7 correlated with BC diagnosis and showed diagnostic performance by ROC analysis (PPV 87.6% at cut-off 6.17; AUC 0.655).
Serum circFBXW7 is significantly down-regulated in breast cancer patients versus healthy controls and correlates with BC diagnosis. It shows potential as a non-invasive diagnostic biomarker based on ROC analysis.
0.4187
The Diagnostic Value of circFBXW7, circABCB10, and circ0103552 Levels in Breast Cancer.
clinical study